We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.65%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.51B
AUM Growth
-$59.4M
(-3.8%)
Cap. Flow
+$92.2M
Cap. Flow
% of AUM
6.09%
Top 10 Holdings %
Top 10 Hldgs %
50.09%
Holding
339
New
32
Increased
81
Reduced
57
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CIH
China Index Holdings Limited American Depository Shares
CIH
|
+$10.8M |
| 2 |
AbbVie
ABBV
|
+$7.55M |
| 3 |
QTT
Qutoutiao Inc. American Depositary Shares
QTT
|
+$4.66M |
| 4 |
Agios Pharmaceuticals
AGIO
|
+$3.3M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
+$3.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BZUN
Baozun
BZUN
|
+$20.3M |
| 2 |
DigitalBridge
DBRG
|
+$14.9M |
| 3 |
Brookdale Senior Living
BKD
|
+$12.7M |
| 4 |
Vipshop
VIPS
|
+$8.37M |
| 5 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
+$6.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.82% |
| 2 | Financials | 5.48% |
| 3 | Industrials | 3.38% |
| 4 | Technology | 2.61% |
| 5 | Communication Services | 2.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
26
DELISTED
Apellis Pharmaceuticals
APLS
| $6.42M | 0.42% |
262,728
-32,000
| -11% | -$651K |
|
|
ALBO
27
DELISTED
Albireo Pharma Inc
ALBO
| $6.26M | 0.41% |
197,005
| – | – |
|
|
RVNC
28
DELISTED
Revance Therapeutics, Inc.
RVNC
| $6.13M | 0.4% |
472,532
| – | – |
|
29
Brookfield
BN
$102B
| $6.05M | 0.4% |
355,947
| – | – |
|
|
SDRL
30
DELISTED
Seadrill Limited Common Stock
SDRL
| $5.99M | 0.4% |
1,438,913
-268,001
| -16% | -$1.76M |
|
|
CBAY
31
DELISTED
Cymabay Therapeutics
CBAY
| $5.93M | 0.39% |
834,096
+42,000
| +5% | +$476K |
|
32
AtriCure
ATRC
$1.77B
| $5.91M | 0.39% |
200,559
| – | – |
|
33
BeyondSpring
BYSI
$46.1M
| $5.69M | 0.38% |
240,000
| – | – |
|
34
MakeMyTrip
MMYT
$4.67B
| $5.19M | 0.34% |
209,385
-85,046
| -29% | -$2.15M |
|
35
Coherus Oncology
CHRS
$217M
| $5.12M | 0.34% |
238,248
+46,000
| +24% | +$799K |
|
36
Amazon
AMZN
$2.5T
| $4.89M | 0.32% |
51,380
-4,000
| -7% | -$373K |
|
37
Ironwood Pharmaceuticals
IRWD
$611M
| $4.75M | 0.31% |
439,853
-13,691
| -3% | -$153K |
|
|
BBU
38
DELISTED
Brookfield Business Partners
BBU
| $4.71M | 0.31% |
133,256
+57,646
| +76% | +$1.43M |
|
39
Newmont
NEM
$98.2B
| $4.66M | 0.31% |
122,353
+21,663
| +22% | +$732K |
|
40
Alphabet (Google) Class A
GOOGL
$3.91T
| $4.65M | 0.31% |
86,400
-8,300
| -9% | -$480K |
|
41
Booking.com
BKNG
$138B
| $4.63M | 0.31% |
62,750
+3,000
| +5% | +$216K |
|
42
Meta Platforms (Facebook)
META
$1.51T
| $4.56M | 0.3% |
24,048
+161
| +0.7% | +$29.4K |
|
43
Mastercard
MA
$477B
| $4.34M | 0.29% |
16,640
-8,218
| -33% | -$2.06M |
|
|
HARP
44
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $4.21M | 0.28% |
32,340
| – | – |
|
45
Visa
V
$677B
| $3.96M | 0.26% |
23,140
-4,050
| -15% | -$663K |
|
|
XOMA
46
DELISTED
Xoma
XOMA
| $3.94M | 0.26% |
266,877
-3,000
| -1% | -$45K |
|
|
MYOK
47
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $3.94M | 0.26% |
81,528
+29,561
| +57% | +$1.44M |
|
48
Alnylam Pharmaceuticals
ALNY
$36.3B
| $3.86M | 0.25% |
54,300
+6,000
| +12% | +$460K |
|
|
DERM
49
DELISTED
Dermira, Inc.
DERM
| $3.82M | 0.25% |
425,626
+95,000
| +29% | +$1.02M |
|
|
CFRX
50
DELISTED
ContraFect Corporation
CFRX
| $3.8M | 0.25% |
9,317
| – | – |
|
Similar funds
NC
T2I
BA
IAA
PNFS
THL
MHC
BWM
Fosun International's Q2 2019 Portfolio in Review
As of Q2 2019, Fosun International held 339 positions worth $1.51B, down 3.8% from $1.57B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Fosun International deployed $92.2M of net new capital in Q2 2019, opening 32 new positions and adding to 81 existing holdings. Its largest new stake was China Index Holdings Limited American Depository Shares: 3,186,499 shares worth $11.3M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was DigitalBridge, an estimated $14.9M trimmed.
- Fosun International's largest Q2 2019 buy was China Index Holdings Limited American Depository Shares: 3,186,499 shares worth $11.3M.
- Fosun International added most to Array Biopharma Inc in Q2 2019, an estimated $3.22M increase.
- Fosun International's biggest Q2 2019 reduction was DigitalBridge, cutting an estimated $14.9M.
- Fosun International fully exited Baozun in Q2 2019, selling an estimated $20.3M.
- Fosun International's ten largest holdings make up 50% of its $1.51B portfolio in Q2 2019.
- Fosun International opened 32 new positions and closed 39 in Q2 2019.
- Fosun International's portfolio value fell 3.8% quarter-over-quarter to $1.51B.
Based on Fosun International's 13F filing for Q2 2019, filed 12 Aug 2019.